Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
暂无分享,去创建一个
B. Dervaux | M. Ridao | X. Lenne | B Dervaux | Á. Gil | X Lenne | J Diez Domingo | A Gil | M Ridao | J A Lluch | J. Díez Domingo | M. Ridao | A. Gil | J. Lluch | J. D. Domingo
[1] J. Seward,et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. , 2005, The Journal of infectious diseases.
[2] W. Edmunds,et al. Varicella vaccination in England and Wales: cost-utility analysis , 2003, Archives of disease in childhood.
[3] J. Arístegui,et al. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. , 2003, Vaccine.
[4] B T Grenfell,et al. The estimation of age-related rates of infection from case notifications and serological data , 1985, Journal of Hygiene.
[5] J. Latour,et al. A cost benefit analysis of routine varicella vaccination in Spain. , 1999, Vaccine.
[6] Á. Gil,et al. Epidemiology of severe varicella-zoster virus infection in Spain. , 2004, Vaccine.
[7] D. Clements. Modified varicella-like syndrome. , 1996, Infectious disease clinics of North America.
[8] E. Lewis,et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. , 1999, The Pediatric infectious disease journal.
[9] M E Halloran,et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. , 1994, American journal of epidemiology.
[10] J. Caro,et al. Instituting a routine varicella vaccination program in Canada: an economic evaluation , 2002, The Pediatric infectious disease journal.
[11] L. Barker,et al. National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999. , 2001, American journal of preventive medicine.
[12] Chen-Kang Chang,et al. Varicella vaccine safety, incidence of breakthrough, and factors associated with breakthrough in Taiwan. , 2003, American journal of infection control.
[13] A. Flahault,et al. Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. , 2003, Vaccine.
[14] S D Stellman,et al. Accuracy of death certificate completion: the need for formalized physician training. , 1996, JAMA.
[15] M. Halloran,et al. Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.
[16] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[17] W. Edmunds,et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus , 2000, Epidemiology and Infection.
[18] M. Wharton,et al. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. , 2000, The Journal of infectious diseases.
[19] A. Gray,et al. An economic analysis of varicella vaccination for health care workers , 1997, Epidemiology and Infection.
[20] B. Yawn,et al. Community impact of childhood varicella infections. , 1997, The Journal of pediatrics.
[21] J. O'Neill,et al. Varicella and paediatric staff: current practice and vaccine cost-effectiveness. , 2003, The Journal of hospital infection.
[22] G. Goldman. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. , 2005, Vaccine.
[23] W. Edmunds,et al. The cost-effectiveness of varicella vaccination in Canada. , 2002, Vaccine.
[24] J. Riddle,et al. A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets. , 1998, Military medicine.
[25] J. Heyse,et al. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. , 2001, The Journal of pediatrics.
[26] S. Wagenpfeil,et al. Effects of varicella vaccination on herpes zoster incidence. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[27] P Wutzler,et al. The cost-effectiveness of routine childhood varicella vaccination in Germany. , 2003, Vaccine.
[28] P. Scuffham,et al. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule. , 1999, Social science & medicine.
[29] A. Gershon. The current status of live attenuated varicella vaccine. , 2001, Archives of virology. Supplementum.
[30] P. Piccoli,et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. , 1999, The Pediatric infectious disease journal.
[31] W. Edmunds,et al. Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] S. Wagenpfeil,et al. Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature , 2004, PharmacoEconomics.
[33] B. McNeil,et al. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.
[34] B. Dervaux,et al. The economic value of childhood varicella vaccination in France and Germany. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[35] W. P. Stephenson,et al. The postmarketing safety profile of varicella vaccine. , 2000, Vaccine.
[36] P. Scuffham,et al. The cost-effectiveness of varicella vaccine programs for Australia. , 1999, Vaccine.
[37] L. Coudeville,et al. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. , 1999, Vaccine.
[38] A. Flahault,et al. Epidemiology of chickenpox in France (1991-1995). , 1998, Journal of epidemiology and community health.
[39] G. Oster,et al. Childhood vaccination against chickenpox: an analysis of benefits and costs. , 1994, The Journal of pediatrics.
[40] P. van Damme,et al. An economic evaluation of varicella vaccination in Italian adolescents. , 2004, Vaccine.
[41] P. van Damme,et al. Costs and benefits of routine varicella vaccination in German children. , 1996, The Journal of infectious diseases.
[42] E. Doorslaer,et al. Economic Evaluations of Varicella Vaccination Programmes , 2003, PharmacoEconomics.
[43] P. Strebel,et al. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. , 1997, JAMA.
[44] R Platt,et al. The epidemiology of varicella and its complications. , 1995, The Journal of infectious diseases.
[45] I. Oyagüez,et al. The Burden of Severe Varicella in Spain, 1995–2000 Period , 2003, European Journal of Epidemiology.
[46] A. Crampin,et al. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data , 2001, BMJ : British Medical Journal.
[47] Y. Okuno,et al. Live vaccine used to prevent the spread of varicella in children in hospital. , 1974, Lancet.
[48] R. Westerling,et al. Comparing hospital discharge records with death certificates: Can the differences be explained? , 2002, Journal of epidemiology and community health.